Publicacións en colaboración con investigadores/as de Hospital POVISA (3)

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

2015

  1. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 4, pp. 430-435

2012

  1. Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors

    Digestive and Liver Disease, Vol. 44, Núm. 11, pp. 904-908